PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION, page-179

  1. 614 Posts.
    lightbulb Created with Sketch. 258
    No, they cannot commence sales (in the US).... It simply means they can begin shipping the product to the investigators running the trials.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.